CRABP2 ′s role in breast cancer may be related to oestrogen signalling that suppresses the ubiquitination of Lats1 to activate the Hippo pathway, which inhibits invasion and metastasis in ER-positive tumours but not in ER-negative tumours [38]. Here, CRABP2 is linked to breast carcinoma.